Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pfizer Buys Option For Vivet In Latest Gene Therapy Tie-Up

Mar 21 2019

• By Jessica Merrill

Wooden cubes on table background - Image

Related Content

Deal Watch: Pfizer Begins 2018 With Two Deals, Including ALS Tie-Up With Sangamo

Jan 04 2018

Deal Watch: Roche Aborts But Regeneron, Amgen and Pfizer Sign Up

Aug 08 2016

Roche $4.8bn Buy Sparks Hemophilia Gene Therapy Race

Feb 25 2019

Biogen By Buying Nightstar Targets Ophthalmology As Emerging Growth Area

Mar 04 2019

How Roche Won The Bidding Battle For Spark

Mar 08 2019

Corporate VCs Wade In With Funds To Pursue Gene Therapy For Wilson Disease

May 04 2017

Related Companies

Pfizer Inc.

Vivet Therapeutics

Bausch Health Companies Inc.

Spark Therapeutics, Inc.

Additional Topics

Deals Regenerative Medicine Rare Diseases Research & Development BioPharmaceutical

More from Deals

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window